Athersys
ATHX
#10562
Rank
C$1.14 M
Marketcap
C$0.01860
Share price
-33.50%
Change (1 day)
-98.95%
Change (1 year)

Earnings for Athersys (ATHX)

Earnings in 2023 (TTM): -C$56.23 Million

According to Athersys's latest financial reports the company's current earnings are C$0.08 Million. In 2022 the company made an earning of -C$0.11 Billion, an increase over its 2021 earnings that were of -C$0.12 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Athersys from 2007 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -C$56.23 Million-47.01%
2022 -C$0.11 Billion-11.54%
2021 -C$0.12 Billion11.14%
2020 -C$0.11 Billion72.2%
2019 -C$62.67 Million77.29%
2018 -C$35.35 Million-22.91%
2017 -C$45.86 Million111.89%
2016 -C$21.65 Million-8.52%
2015 -C$23.66 Million-40.81%
2014 -C$39.97 Million18.62%
2013 -C$33.7 Million
2011 -C$18.99 Million19.71%
2010 -C$15.86 Million-26.28%
2009 -C$21.52 Million-18.21%
2008 -C$26.31 Million-8.28%
2007 -C$28.68 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
C$11.35 B-19,840.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$16.32 B-28,479.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$11.06 B-19,335.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
-C$4.34 Billion 7,430.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
C$44.63 B-77,672.91%๐Ÿ‡บ๐Ÿ‡ธ USA
United States Lime & Minerals
USLM
C$0.22 B-496.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Arena Pharmaceuticals
ARNA
-C$0.87 Billion 1,401.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$31.81 B-55,389.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$12.53 B-21,890.77%๐Ÿ‡ซ๐Ÿ‡ท France